Lipofermata
CAS No. 297180-15-5
Lipofermata ( —— )
Catalog No. M24217 CAS No. 297180-15-5
Lipofermata is a fatty acid transport protein (FATP) inhibitor that prevents lipid transport to melanoma cells and reduces melanoma growth and invasion.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 69 | In Stock |
|
5MG | 115 | In Stock |
|
10MG | 205 | In Stock |
|
25MG | 340 | In Stock |
|
50MG | 475 | In Stock |
|
100MG | 650 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLipofermata
-
NoteResearch use only, not for human use.
-
Brief DescriptionLipofermata is a fatty acid transport protein (FATP) inhibitor that prevents lipid transport to melanoma cells and reduces melanoma growth and invasion.
-
DescriptionLipofermata is a fatty acid transport protein (FATP) inhibitor that prevents lipid transport to melanoma cells and reduces melanoma growth and invasion.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFATP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number297180-15-5
-
Formula Weight360.2
-
Molecular FormulaC15H10BrN3OS
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (277.60 mM; Need ultrasonic)
-
SMILESO=C1NC2=C(C=C(Br)C=C2)C13SC(C4=CC=CC=C4)=NN3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang M,et al. Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins. Cancer Discov. 2018 Aug;8(8):1006-1025.
molnova catalog
related products
-
Bisphenoxyethanolflu...
Bisphenoxyethanolfluorene a high stability of the new type of organic chemical raw materials, mainly used for synthesis of heat resistance, excellent transparency and high refractive index of polymer monomer.
-
AMARA peptide
AMARA peptide is a substrate for SIK and AMPK.AMARA peptide is a minimal substrate of several members of the protein kinases family. It consists of the phosphorylation site for AMP-activated Protein Kinase (AMPK).
-
WKYMVM
WKYMVM is a N-formyl peptide receptor (FPR1) agonist.